A carregar...

Erlotinib in the treatment of advanced pancreatic cancer

Single agent gemcitabine has been the mainstay of therapy for advanced pancreatic cancer over the past decade. Multiple trials of newer chemotherapeutic agents both alone and in combination have yielded disappointing results, spurring the ongoing search for new agents and combinations in this aggres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kelley, Robin K, Ko, Andrew H
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2727779/
https://ncbi.nlm.nih.gov/pubmed/19707431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!